INCYTE CORP - 8-K Filing

Incyte Corp cancels planned Phase 3 MAESTRA-3 study for INCB123667 in ovarian cancer (Items: 8.01 Other Events)

2 articles from 2 sources · updated November 13, 2026, 22:11 UTC

Coverage

• Incyte Cancels Phase 3 Trial of Ovarian Cancer Candidate INCB123667 Seeking Alpha · November 13, 2026, 22:09 UTC
• INCYTE CORP - 8-K Filing SEC EDGAR · November 13, 2026, 21:09 UTC